Nafithromycin clinical trials
Also written WCK 4873.
- studies test it
- 6
- open now
- 0
- in phase 3
- 0
- first study started
- 2013
How each study uses nafithromycin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
6 studies that test it; most in 2013 (2)
| Year | Studies |
|---|---|
| 2013 | 2 |
| 2015 | 1 |
| 2016 | 2 |
| 2019 | 1 |
Who runs them
Industry 6 · Other 0
Studies
Open first, then newest update. How each study uses nafithromycin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 6
- Phase II Study of Oral Nafithromycin in CABPCompletedPhase 2WockhardtNCT02903836Written as Nafithromycin 800 mg 3 days
- Safety, Tolerability, and Pharmacokinetics of Multiple Doses of Intravenous NafithromycinCompletedPhase 1WockhardtNCT03981887Written as Nafithromycin
- Evaluate The Safety, Tolerability and Pharmacokinetics Of Multiple Ascending Oral Doses Of WCK 4873 In Healthy Adult VolunteersCompletedPhase 1WockhardtNCT03979859Written as WCK 4873
- The Safety, Tolerability And Pharmacokinetics Of Single Ascending Doses And The Effect Of Food On Oral WCK 4873 In Healthy Adult VolunteersCompletedPhase 1WockhardtNCT03926962Written as WCK 4873
- A Phase 1 Pharmacokinetic Study of Single-Ascending Doses of Intravenous Nafithromycin in Healthy Adult SubjectsCompletedPhase 1WockhardtNCT02770404Written as Nafithromycin
- Study to Determine and Compare Plasma and Intrapulmonary Concentrations of WCK 4873 in Healthy Adult Human SubjectsCompletedPhase 1WockhardtNCT02453529Written as WCK 4873
Codes
What other systems call nafithromycin · ClinicalTrials.gg INT000933
- MeSH (NLM) C000627038nafithromycinConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 75F74Y2R70NAFITHROMYCINConfirmed FDA, NLM, Wikidata
- Wikidata Q27266375nafithromycinConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C166991NafithromycinOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000627038 | nafithromycin | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 75F74Y2R70 | NAFITHROMYCIN | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q27266375 | nafithromycin | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C166991 | Nafithromycin | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.